Table 1 Patient Characteristics by Treatment Group
From: Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer
Characteristics | Total | S | RT | S + RT | P |
|---|---|---|---|---|---|
n(%) | 568(100) | 238(41.9) | 216(38.0) | 114(20.1) | |
Gender | <0.001 | ||||
Male | 397(69.9) | 152 (63.9) | 143 (66.2) | 96(84.2) | |
Female | 177(31.2) | 86 (36.4) | 73 (33.8) | 18(15.8) | |
age (year) | 0.002 | ||||
<60 | 276(48.6) | 118(49.6) | 88(40.7) | 70(61.4) | |
≥ 60 | 292(51.4) | 120(50.4) | 128(59.3) | 44(38.6) | |
LNM | <0.001 | ||||
No | 252(44.4) | 135(56.7) | 67(31.0) | 50(43.9) | |
Yes | 316(55.6) | 103(43.3) | 149(69.0) | 64(56.1) | |
cT stage | <0.001 | ||||
T0–2 | 127(22.4) | 81(34.0) | 20(9.3) | 26(22.8) | |
T3 | 247(43.5) | 121(50.8) | 65(30.1) | 61(53.5) | |
T4 | 194(34.2) | 36(15.1) | 131(60.6) | 27(23.7) | |
cN stage | <0.001 | ||||
N0 | 285(50.2) | 153(64.3) | 67(31.0) | 65(57.0) | |
N1 | 185(32.6) | 61(25.6) | 91(42.1) | 33(28.9) | |
N2–3 | 99(17.3) | 24(10.1) | 58(26.9) | 16(14.0) | |
cTNM stage | |||||
I-II | 261(46.0) | 157(66.0) | 50(23.1) | 54(47.4) | <0.001 |
III | 117(20.6) | 44(18.5) | 41(19.0) | 32(28.1) | |
IV | 190(33.5) | 37(15.5) | 125(57.9) | 28(24.6) | |
Tumor length | <0.001 | ||||
≤ 5 cm | 363(63.9) | 180(75.6) | 119(55.1) | 64(56.1) | |
>5 cm | 205(36.1) | 58(24.4) | 97(44.9) | 50(43.9) | |
Chemotherapy | <0.001 | ||||
Yes | 370(65.1) | 113(47.5) | 163(75.5) | 94(82.5) | |
No | 198(34.9) | 125(52.5) | 53(24.5) | 20(17.5) |